The
reactions of chlorogermylene MsFluind
tBu-GeCl 1, supported by a sterically
encumbered hydrindacene ligand MsFluind
tBu, with NaPCO(dioxane)2.5 and NaAsCO(18-c-6) in the presence of trimethylphosphine afforded trimethylphosphine-stabilized
germylidenyl-phosphinidene 2 and -arsinidene 3, respectively. Structural and computational investigations reveal
that the Ge–E′ bond (E′ = P and As) features
a multiple-bond character. 2 and 3 exhibit
diverse reactivity toward trimethylsilylacetylene and 4-tetrabutylphenylacetylene.
Specifically, 2 underwent cycloadditions with both alkynes
affording the first six-membered aromatic phosphagermabenzen-1-ylidenes 4 and 5, respectively, through the heavier isocyanide
intermediate MsFluind
tBu-PGe.
In contrast, 3 could serve as a synthetic equivalent
of heavier isocyanides and nitriles when treated with trimethylsilylacetylene
and 4-tetrabutylphenylacetylene yielding arsagermene 6 and arsolylgermylene 7, respectively. The reaction
mechanisms for the cycloadditions were investigated through density
functional theory calculations. The reactivity studies highlight the
potential of 2 and 3 in accessing heavy
main-group element-containing heterocycles.
The reaction of the carbazole ligand supported Ga(I) compound LGa(THF) (3) and 1-azido-4-(tert-butyl)benzene (ArN3) afforded the first stable tetrazagallole LGaN4Ar2 (4) bearing a three-coordinate Ga atom. Reduction of 4 with...
The first germanimidoyl chloride MsFluindtBu-Ge(Cl)=NMes (2, where MsFluindtBu is a bulky hydrindacene skeleton) was synthesized through the reaction of MsFluindtBu-GeCl (1) and mesityl azide (MesN3). Contrastingly, treatment of 1 with...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.